查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599017

到 2033 年基層醫療POC 診斷的全球市場機會和策略

Primary Care POC Diagnostics Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 321 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2018年，全球基層醫療POC診斷市場價值為112.4242億美元，到2023年複合年成長率將超過6.00%。

感染疾病高發

在歷史時期，感染疾病的高發生率推動了基層醫療POC 診斷市場的成長。由於初級保健機構需要快速、準確的檢測，人類免疫力缺乏病毒 (HIV)、結核病、流感和 COVID-19 等感染疾病的增加推動了對 POC 診斷的需求。 POC 診斷使醫護人員能夠立即進行檢測，從而實現快速診斷和治療，這對於有效管理感染疾病爆發至關重要。例如，總部位於瑞士的國際非政府組織世界經濟論壇預計，2023年，流感、呼吸道融合細胞病毒（RSV）等感染疾病將因疫情而增加。截至 2023 年 2 月，美國估計有 2,400 萬人感染流感，26 萬人住院治療，1.6 萬人死亡。此外，根據世界衛生組織(WHO)稱，到2022年，將有1,060萬人感染結核病，130萬人將死於結核病。因此，感染疾病的高盛行率推動了基層醫療POC診斷市場的成長。

目錄

第1章執行摘要

  • 基層醫療POC 診斷：市場吸引力和宏觀經濟狀況

第2章 目錄

第3章表格一覽

第4章圖表一覽

第5章 報告結構

第6章市場特徵

  • 一般市場定義
  • 概述
  • 基層醫療POC 診斷市場定義和細分
  • 按產品：市場區隔
    • 血糖監測
    • 心臟代謝檢測產品
    • 傳染病檢查產品
    • 血液凝固檢驗產品
    • 懷孕和生育測試產品
    • 腫瘤或癌症標記檢測產品
    • 膽固醇檢測產品
    • 其他產品
  • 按處方箋：市場細分
    • 基於處方箋
    • 非處方藥 (OTC) 測試
  • 按最終用途細分市場
    • 醫院
    • 診斷中心
    • 研究室
    • 居家照護設置
    • 數位健康
    • 其他用途

第7章 主要市場趨勢

  • 透過人工智慧整合提高診斷準確性和效率
  • 開發多條件就地檢驗設備以簡化診斷
  • 介紹可以更快提供結果的就地檢驗系統
  • 重點在於POC測試產品的核准與清關，確保競爭優勢

第8章基層醫療POC 診斷市場：宏觀經濟情景

  • COVID-19 的影響：基層醫療POC 診斷市場
  • 烏克蘭戰爭的影響：基層醫療POC 診斷市場
  • 高通膨的影響：基層醫療POC 診斷市場

第9章世界市場規模與成長

  • 市場規模
  • 2018-2023 年市場成長表現
    • 2018-2023年市場促進因素
    • 2018-2023年市場限制因素
  • 市場成長預測，2023-2028，2033F
    • 2023-2028年市場促進因素
    • 2023-2028年市場限制因素

第10章全球基層醫療POC 診斷市場：細分

  • 全球基層醫療POC 診斷市場：按產品分類的績效與預測，2018-2023、2028F、2033F
  • 全球基層醫療POC 診斷市場：按處方箋的實際情況和預測，2018-2023、2028F、2033F
  • 全球基層醫療POC 診斷市場：按最終用途分類的實際情況和預測，2018-2023、2028F、2033F
  • 全球數位醫療市場規模、POCT 表現及預測，2018-2023、2028F、2033F

第11章基層醫療POC 診斷市場：區域與國家分析

  • 全球基層醫療POC 診斷市場：按地區分類的表現和預測，2018-2023、2028F、2033F
  • 全球基層醫療POC 診斷市場：按國家、績效和預測，2018-2023 年、2028 年、2033 年

第12章亞太市場

第13章西歐市場

第14章 東歐市場

第15章 北美市場

第16章 南美洲市場

第17章 中東市場

第18章 非洲市場

第19章 競爭格局及公司概況

  • 公司簡介
  • F. Hoffman-La Roche Ltd
  • Siemens Healthineers AG
  • QuidelOrtho Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc

第20章 其他大型創新企業

  • Becton, Dickinson and Company
  • OraSure Technologies, Inc
  • Sekisui Chemical Co., Ltd.（Sekisui Diagnostics）
  • Danaher Corporation
  • bioMerieux SA
  • Cardinal Health, Inc
  • Werfen
  • Nova Biomedical
  • Randox Laboratories Ltd
  • EKF Diagnostics
  • PTS Diagnostics
  • Biosynex SA
  • Trinity Biotech plc
  • AccuBiotech Co. Ltd
  • Anbio Biotechnology（Anbio）

第21章 競爭基準化分析

第22章競爭對手儀表板

第23章 重大併購

  • Roche Holding AG Acquired LumiraDx
  • SD Biosensor Inc And SJL Partners Acquired Meridian Bioscience Inc.
  • Shineco Inc Acquired Changzhou Biowin Pharmaceutical Co
  • Bio-Rad Laboratories Inc Acquired Curiosity Diagnostics
  • Roche Holding AG Acquired GenMark Diagnostics
  • Thermo Fisher Scientific Inc Acquired Mesa Biotech Inc

第24章機遇與策略

  • 2028 年全球基層醫療POC 診斷市場：提供新機會的國家
  • 2028 年全球基層醫療POC 診斷市場：提供新機會的細分市場
  • 2028 年全球基層醫療POC 診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭策略

第25章 全球基層醫療POC診斷市場的結論與建議

  • 結論
  • 推薦
    • 產品
    • 地方
    • 價格
    • 晉升
    • 人們

第26章附錄

簡介目錄
Product Code: o&s1411

Primary care point-of-care (POC) diagnostics refer to medical diagnostic tools and tests that are used directly at the point of care, typically in a primary care settings, such as hospitals, nursing homes, clinicians' offices, homes and others. These tests provide immediate results, enabling healthcare providers to make swift decisions about a patient's treatment.

The primary care POC diagnostics market consists of sales, by entities (organizations, sole traders and partnerships), of primary care POC diagnostic tools and tests to deliver rapid, accurate and actionable data without the need to send samples to a centralized laboratory.

The global primary care POC diagnostics market was valued at $11,242.42 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.00%.

High Prevalence Of Infectious Diseases

The high prevalence of infectious diseases drove the growth of the primary care POC diagnostics market during the historic period. The rise in infectious diseases such as human immunodeficiency virus (HIV), tuberculosis, influenza, COVID-19 and others, drove demand for POC diagnostics due to their need for rapid, accurate detection in primary care settings. POC diagnostics enabled healthcare providers to perform immediate testing, leading to quicker diagnosis and treatment, which is crucial in managing infectious outbreaks effectively. For instance, in 2023, according to the World Economic Forum, a Switzerland-based international non-governmental organization, infections such as influenza and respiratory syncytial virus (RSV) have increased since the pandemic. In the USA, an estimated 24 million illnesses, 260,000 hospitalizations and 16,000 deaths from the influenza have occurred as of February 2023. Additionally, in 2022, according to the World Health Organization, 10.6 million people were infected with tuberculosis globally, with 1.3 million deaths attributed to tuberculosis. Therefore, the high prevalence of infectious diseases drove the growth of the primary care POC diagnostics market.

Development Of Multi-Condition POC Testing Devices To Streamline Diagnostics

Major companies operating in the primary care POC diagnostics market are developing POC testing device capable of diagnosing multiple health conditions. These multi-diagnostic tools enable healthcare providers to conduct various tests, such as for infectious diseases, chronic conditions and metabolic disorders, using a single device. This streamlines diagnostics, reduces time to results and improves patient care by allowing immediate, comprehensive assessments during a single visit. For example, in January 2023, Cipla Limited, an India-based pharmaceutical company, launched a POC testing device for multiple health conditions called Cippoint. Cippoint is engineered to test for various health conditions, thereby streamlining the diagnostic process. It is an immunofluorescence-based quantitative analyzer that allows healthcare professionals to get test results in 3 to 15 minutes. This makes it possible to make clinical decisions more quickly and efficiently. Cippoint allows healthcare providers to conduct tests at the site of patient care, reducing the need for laboratory visits and expediting diagnosis.

The global primary care POC diagnostics market is concentrated, with large players operating in the market. The top ten competitors in the market made up to 41.17% of the total market in 2023.

Primary Care POC Diagnostics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global primary care POC diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for primary care POC diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The primary care POC diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider primary care POC diagnostics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by prescription and by end-use.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the primary care POC diagnostics market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by prescription and by end-use in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for primary care POC diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Glucose Monitoring; Cardiometabolic Testing Products; Infectious Disease Testing Products, Coagulation Testing Products, Pregnancy And Fertility Testing Products; Tumor Or Cancer Marker Testing Products; Cholesterol Testing Products; Other Products
  • 2) By Prescription: Prescription-Based; Over-The-Counter (OTC) Testing
  • 3) By End-Use: Hospitals; Diagnostic Centers; Research Laboratories; Home-Care Settings; Digital Health; Other End-Uses
  • Companies Mentioned: F. Hoffmann-La Roche AG; Siemens Healthineers AG; QuidelOrtho Corporation; Abbott Laboratories; Thermo Fisher Scientific Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; primary care POC diagnostics indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Primary Care POC Diagnostics - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Primary Care POC Diagnostics Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Glucose Monitoring
    • 6.4.2 Cardiometabolic Testing Products
    • 6.4.3 Infectious Disease Testing Products
    • 6.4.4 Coagulation Testing Products
    • 6.4.5 Pregnancy And Fertility Testing Products
    • 6.4.6 Tumor Or Cancer Marker Testing Products
    • 6.4.7 Cholesterol Testing Products
    • 6.4.8 Other Products
  • 6.5 Market Segmentation By Prescription
    • 6.5.1 Prescription-Based
    • 6.5.2 Over-The-Counter (OTC) Testing
  • 6.6 Market Segmentation By End-Use
    • 6.6.1 Hospitals
    • 6.6.2 Diagnostic Centers
    • 6.6.3 Research Laboratories
    • 6.6.4 Home-Care Settings
    • 6.6.5 Digital Health
    • 6.6.6 Other End-Uses

7 Major Market Trends

  • 7.1 Integration Of AI To Enhance Diagnostic Accuracy And Efficiency
  • 7.2 Development Of Multi-Condition Point-Of-Care Testing Devices To Streamline Diagnostics
  • 7.3 Introduction Of Point Of Care Testing Systems With Significant Faster Results
  • 7.4 Focus On POC Testing Products Approvals And Clearances To Secure A Competitive Advantage

8 Primary Care POC Diagnostics Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Primary Care POC Diagnostics Market
  • 8.2 Impact Of The War In Ukraine On The Primary Care POC Diagnostics Market
  • 8.3 Impact Of High Inflation On The Primary Care POC Diagnostics Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Primary Care POC Diagnostics Market Segmentation

  • 10.1 Global Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Digital Health In POCT Market Size, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Primary Care POC Diagnostics Market, Regional and Country Analysis

  • 11.1 Global Primary Care POC Diagnostics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Primary Care POC Diagnostics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Primary Care POC Diagnostics Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Investments
    • 12.9.11 Major Companies
  • 12.10 China Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Primary Care POC Diagnostics Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major companies
  • 14.3 Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Primary Care POC Diagnostics Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Primary Care POC Diagnostics Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 South America Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Primary Care POC Diagnostics Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Major Companies
  • 18.3 Africa Primary Care POC Diagnostics Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Primary Care POC Diagnostics Market, Segmentation By Prescription, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Primary Care POC Diagnostics Market, Segmentation By End-Use, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 F. Hoffman-La Roche Ltd
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial Overview
  • 19.3 Siemens Healthineers AG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 QuidelOrtho Corporation
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Abbott Laboratories
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Financial Overview
  • 19.6 Thermo Fisher Scientific Inc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Becton, Dickinson and Company
    • 20.1.1 Company Overview
    • 20.1.2 Products and Services
  • 20.2 OraSure Technologies, Inc
    • 20.2.1 Company Overview
    • 20.2.2 Products and Services
  • 20.3 Sekisui Chemical Co., Ltd. (Sekisui Diagnostics)
    • 20.3.1 Company Overview
    • 20.3.2 Products and Services
  • 20.4 Danaher Corporation
    • 20.4.1 Company Overview
    • 20.4.2 Products and Services
  • 20.5 bioMerieux SA
    • 20.5.1 Company Overview
    • 20.5.2 Products and Services
  • 20.6 Cardinal Health, Inc
    • 20.6.1 Company Overview
    • 20.6.2 Products and Services
  • 20.7 Werfen
    • 20.7.1 Company Overview
    • 20.7.2 Products and Services
  • 20.8 Nova Biomedical
    • 20.8.1 Company Overview
    • 20.8.2 Products and Services
  • 20.9 Randox Laboratories Ltd
    • 20.9.1 Company Overview
    • 20.9.2 Products and Services
  • 20.10 EKF Diagnostics
    • 20.10.1 Company Overview
    • 20.10.2 Products and Services
  • 20.11 PTS Diagnostics
    • 20.11.1 Company Overview
    • 20.11.2 Products and Services
  • 20.12 Biosynex SA
    • 20.12.1 Company Overview
    • 20.12.2 Products and Services
  • 20.13 Trinity Biotech plc
    • 20.13.1 Company Overview
    • 20.13.2 Products and Services
  • 20.14 AccuBiotech Co. Ltd
    • 20.14.1 Company Overview
    • 20.14.2 Products and Services
  • 20.15 Anbio Biotechnology (Anbio)
    • 20.15.1 Company Overview
    • 20.15.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Roche Holding AG Acquired LumiraDx
  • 23.2 SD Biosensor Inc And SJL Partners Acquired Meridian Bioscience Inc.
  • 23.3 Shineco Inc Acquired Changzhou Biowin Pharmaceutical Co
  • 23.4 Bio-Rad Laboratories Inc Acquired Curiosity Diagnostics
  • 23.5 Roche Holding AG Acquired GenMark Diagnostics
  • 23.6 Thermo Fisher Scientific Inc Acquired Mesa Biotech Inc

24 Opportunities And Strategies

  • 24.1 Global Primary Care POC Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Primary Care POC Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Primary Care POC Diagnostics Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Primary Care POC Diagnostics Global Market Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer